arsenic has been researched along with 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, LW; Hsieh, DP; Lee, HL; Lin, P; Tsai, MH; Ueng, YF; Wu, JP | 1 |
Chung, CJ; Hsueh, YM; Huang, CY; Lee, HL; Lin, P; Pu, YS; Su, CT; Wu, CC | 1 |
2 other study(ies) available for arsenic and 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone
Article | Year |
---|---|
Enhancements of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism and carcinogenic risk via NNK/arsenic interaction.
Topics: Animals; Arsenic; Body Weight; Carcinogens; Cytochrome P-450 Enzyme System; DNA Adducts; Growth; Hydroxylation; Male; Mice; Mice, Inbred ICR; Nitrosamines; Risk Factors; RNA, Messenger | 2008 |
Joint effect of arsenic methylation profile and NNK metabolites on urothelial carcinoma.
Topics: Arsenic; Carcinoma, Transitional Cell; Case-Control Studies; Humans; Methylation; Nitrosamines; Pyridines; Risk; Smoking; Urologic Neoplasms | 2012 |